ALACRiS Theranostics GmbH

ALACRiS Theranostics GmbH is a biotechnology company specializing in precision oncology and systems medicine. The company focuses on developing innovative approaches for cancer precision medicine, biomarker discovery, and drug development, providing accredited diagnostics services that combine Next Generation Sequencing (NGS) with a proprietary bioinformatics pipeline to improve patient outcomes and accelerate discovery.